Lonza Signs Development and Manufacturing Agreement with Genmab
06:10 AM | October 25, 2011 | Deepti Ramesh
Lonza says it has signed a development and manufacturing agreement with biotechnology company Genmab (Copenhagen, Denmark) for a novel antibody drug conjugate (ADC), HuMax-TF. This agreement secures a...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.